{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:34:59Z","timestamp":1784946899982,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","exphem.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.exphem.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T03:16:27Z","timestamp":1494558987000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["With me or against me: Tumor suppressor and drug resistance activities of SAMHD1"],"prefix":"10.1016","volume":"52","author":[{"given":"Nikolas","family":"Herold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean G.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sanjiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Kutzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Hed","family":"Myrberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia B.J.","family":"Paulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thale Kristin","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Helleday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Inge","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2017.05.001_bib1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng.373","article-title":"Mutations involved in Aicardi\u2013Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response","volume":"41","author":"Rice","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2017.05.001_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-0036-1592307","article-title":"Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi\u2013Goutieres syndrome and beyond","volume":"47","author":"Livingston","year":"2016","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.exphem.2017.05.001_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"167a","author":"Crow","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.exphem.2017.05.001_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12977-015-0174-4","article-title":"SAMHD1 specifically restricts retroviruses through its RNase activity","volume":"12","author":"Choi","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.exphem.2017.05.001_bib5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm.3626","article-title":"The ribonuclease activity of SAMHD1 is required for HIV-1 restriction","volume":"20","author":"Ryoo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2017.05.001_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.bbrc.2016.07.013","article-title":"SAMHD1, the Aicard\u2013Goutieres syndrome gene and retroviral restriction factor, is a phosphorolytic ribonuclease rather than a hydrolytic ribonuclease","volume":"477","author":"Ryoo","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2017.05.001_bib7","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1093\/nar\/gkv633","article-title":"SAMHD1 is a single-stranded nucleic acid binding protein with no active site-associated nuclease activity","volume":"43","author":"Seamon","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2017.05.001_bib8","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nm.4163","article-title":"SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity","volume":"22","author":"Antonucci","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2017.05.001_bib9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.001_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.001_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature10623","article-title":"HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase","volume":"480","author":"Goldstone","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.001_bib12","doi-asserted-by":"crossref","first-page":"43596","DOI":"10.1074\/jbc.C111.317628","article-title":"Aicardi\u2013Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase","volume":"286","author":"Powell","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.05.001_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1107\/S1399004714027527","article-title":"The mechanism of substrate-controlled allosteric regulation of SAMHD1 activated by GTP","volume":"71","author":"Zhu","year":"2015","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.exphem.2017.05.001_bib14","doi-asserted-by":"crossref","first-page":"25001","DOI":"10.1074\/jbc.C113.493619","article-title":"GTP is the primary activator of the anti-HIV restriction factor SAMHD1","volume":"288","author":"Amie","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.05.001_bib15","doi-asserted-by":"crossref","first-page":"E1843","DOI":"10.1073\/pnas.1401706111","article-title":"GTP activator and dNTP substrates of HIV-1 restriction factor SAMHD1 generate a long-lived activated state","volume":"111","author":"Hansen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2017.05.001_bib16","doi-asserted-by":"crossref","first-page":"32617","DOI":"10.1074\/jbc.M114.591958","article-title":"Structural basis of allosteric activation of sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1) by nucleoside triphosphates","volume":"289","author":"Koharudin","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.05.001_bib17","doi-asserted-by":"crossref","first-page":"29428","DOI":"10.1074\/jbc.M115.663658","article-title":"Structural insights into the high-efficiency catalytic mechanism of the sterile alpha-motif\/histidine\u2013aspartate domain-containing protein","volume":"290","author":"Li","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.05.001_bib18","doi-asserted-by":"crossref","first-page":"18339","DOI":"10.1074\/jbc.M114.571091","article-title":"Allosteric regulation of the human and mouse deoxyribonucleotide triphosphohydrolase sterile alpha-motif\/histidine-aspartate domain-containing protein 1 (SAMHD1)","volume":"289","author":"Miazzi","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.05.001_bib19","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/ncomms3722","article-title":"Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase","volume":"4","author":"Zhu","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2017.05.001_bib20","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: Biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2017.05.001_bib21","doi-asserted-by":"crossref","first-page":"14272","DOI":"10.1073\/pnas.1312033110","article-title":"The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells","volume":"110","author":"Franzolin","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2017.05.001_bib22","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.4049\/jimmunol.1400873","article-title":"Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells","volume":"193","author":"Pauls","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2017.05.001_bib23","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1080\/15384101.2015.1030558","article-title":"Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages","volume":"14","author":"Ruiz","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exphem.2017.05.001_bib24","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.celrep.2013.03.017","article-title":"Phosphorylation of SAMHD1 by cyclin A2\/CDK1 regulates its restriction activity toward HIV-1","volume":"3","author":"Cribier","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2017.05.001_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.chom.2014.11.009","article-title":"Cyclin L2 is a critical HIV dependency factor in macrophages that controls SAMHD1 abundance","volume":"17","author":"Kyei","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.exphem.2017.05.001_bib26","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/QAD.0000000000000399","article-title":"Palbociclib, a selective inhibitor of cyclin-dependent kinase4\/6, blocks HIV-1 reverse transcription through the control of sterile alpha motif and HD domain-containing protein-1 (SAMHD1) activity","volume":"28","author":"Pauls","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.exphem.2017.05.001_bib27","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.4049\/jimmunol.1203226","article-title":"Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 through the upregulation of SAMHD1","volume":"190","author":"Pauls","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2017.05.001_bib28","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1021\/acs.biochem.6b00627","article-title":"Substrate specificity of SAMHD1 triphosphohydrolase activity is controlled by deoxyribonucleoside triphosphates and phosphorylation at Thr592","volume":"55","author":"Jang","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.exphem.2017.05.001_bib29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/bloodadvances.2016000745","article-title":"Increased iron export by ferroportin induces restriction of HIV-1 infection in sickle cell disease","volume":"1","author":"Kumari","year":"2016","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2017.05.001_bib30","doi-asserted-by":"crossref","first-page":"604","DOI":"10.15252\/embj.201696025","article-title":"A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages","volume":"36","author":"Mlcochova","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2017.05.001_bib31","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1128\/JVI.00155-14","article-title":"Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1","volume":"88","author":"St Gelais","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2017.05.001_bib32","doi-asserted-by":"crossref","first-page":"26332","DOI":"10.1074\/jbc.M116.753947","article-title":"A putative cyclin-binding motif in human SAMHD1 contributes to protein phosphorylation, localization, and stability","volume":"291","author":"St Gelais","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.05.001_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.virol.2015.10.024","article-title":"Phosphorylation of mouse SAMHD1 regulates its restriction of human immunodeficiency virus type 1 infection, but not murine leukemia virus infection","volume":"487","author":"Wang","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.exphem.2017.05.001_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.chom.2013.03.005","article-title":"The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation","volume":"13","author":"White","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.exphem.2017.05.001_bib35","doi-asserted-by":"crossref","first-page":"31353","DOI":"10.1038\/srep31353","article-title":"Effects of T592 phosphomimetic mutations on tetramer stability and dNTPase activity of SAMHD1 can not explain the retroviral restriction defect","volume":"6","author":"Bhattacharya","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2017.05.001_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nm.4265","article-title":"Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies","volume":"23","author":"Herold","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2017.05.001_bib37","doi-asserted-by":"crossref","first-page":"e1005194","DOI":"10.1371\/journal.ppat.1005194","article-title":"Phospho-dependent regulation of SAMHD1 oligomerisation couples catalysis and restriction","volume":"11","author":"Arnold","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.exphem.2017.05.001_bib38","doi-asserted-by":"crossref","first-page":"11516","DOI":"10.1128\/JVI.01642-13","article-title":"Restriction of virus infection but not catalytic dNTPase activity is regulated by phosphorylation of SAMHD1","volume":"87","author":"Welbourn","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2017.05.001_bib39","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1074\/jbc.M116.743740","article-title":"A highly active isoform of lentivirus restriction factor SAMHD1 in mouse","volume":"292","author":"Bloch","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.05.001_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jprot.2013.11.014","article-title":"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome","volume":"96","author":"Bian","year":"2014","journal-title":"J Proteomics"},{"key":"10.1016\/j.exphem.2017.05.001_bib41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/pr300630k","article-title":"Toward a comprehensive characterization of a human cancer cell phosphoproteome","volume":"12","author":"Zhou","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1016\/j.exphem.2017.05.001_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2017.03.019","article-title":"SAMHD1 is active in cycling cells permissive to HIV-1 infection","volume":"142","author":"Badia","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.exphem.2017.05.001_bib43","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1021\/acs.biochem.6b00986","article-title":"Single-stranded nucleic acids bind to the tetramer interface of SAMHD1 and prevent formation of the catalytic homotetramer","volume":"55","author":"Seamon","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.exphem.2017.05.001_bib44","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2016.6888","article-title":"The SAMHD1 dNTP triphosphohydrolase is controlled by a redox switch","author":"Mauney","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.exphem.2017.05.001_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2013.12.007","article-title":"The role of reactive oxygen species and metabolism on cancer cells and their microenvironment","volume":"25","author":"Costa","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.exphem.2017.05.001_bib46","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/jid.2013.311","article-title":"Downregulation of SAMHD1 expression correlates with promoter DNA methylation in Sezary syndrome patients","volume":"134","author":"de Silva","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.exphem.2017.05.001_bib47","doi-asserted-by":"crossref","first-page":"9284","DOI":"10.1074\/jbc.M112.447201","article-title":"Promoter methylation regulates SAMHD1 gene expression in human CD4+ T cells","volume":"288","author":"de Silva","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.05.001_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbrc.2014.10.153","article-title":"SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation","volume":"455","author":"Wang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2017.05.001_bib49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.001_bib50","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1096\/fj.14-254862","article-title":"The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling","volume":"28","author":"Lindskog","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.exphem.2017.05.001_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13148-016-0237-y","article-title":"A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers","volume":"8","author":"Diesch","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.exphem.2017.05.001_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/15384101.2017.1314407","article-title":"SAMHD1 protects cancer cells from various nucleoside-based antimetabolites","author":"Herold","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exphem.2017.05.001_bib53","doi-asserted-by":"crossref","first-page":"e0169052","DOI":"10.1371\/journal.pone.0169052","article-title":"Substrates and Inhibitors of SAMHD1","volume":"12","author":"Hollenbaugh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2017.05.001_bib54","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1042\/BCJ20160302","article-title":"The nucleotidohydrolases DCTPP1 and dUTPase are involved in the cellular response to decitabine","volume":"473","author":"Requena","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.exphem.2017.05.001_bib55","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2017.05.001_bib56","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2012-05-433540","article-title":"Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns","volume":"120","author":"Schuh","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.001_bib57","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2013-04-490847","article-title":"SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage","volume":"123","author":"Clifford","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.001_bib58","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1073\/pnas.1519128113","article-title":"Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance","volume":"113","author":"Rentoft","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2017.05.001_bib59","doi-asserted-by":"crossref","first-page":"e1004846","DOI":"10.1371\/journal.pgen.1004846","article-title":"Increased and imbalanced dNTP pools symmetrically promote both leading and lagging strand replication infidelity","volume":"10","author":"Buckland","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.exphem.2017.05.001_bib60","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/nar\/gkv1298","article-title":"Genome-wide analysis of the specificity and mechanisms of replication infidelity driven by imbalanced dNTP pools","volume":"44","author":"Watt","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2017.05.001_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0027-5107(88)90076-0","article-title":"Mutagenesis and deoxyribonucleotide pool imbalance","volume":"200","author":"Kunz","year":"1988","journal-title":"Mutat Res"},{"key":"10.1016\/j.exphem.2017.05.001_bib62","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ncomms1363","article-title":"Pyrimidine pool imbalance induced by BLM helicase deficiency contributes to genetic instability in Bloom syndrome","volume":"2","author":"Chabosseau","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2017.05.001_bib63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cell.2011.03.044","article-title":"Nucleotide deficiency promotes genomic instability in early stages of cancer development","volume":"145","author":"Bester","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2017.05.001_bib64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0014-4827(89)90090-6","article-title":"The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells","volume":"181","author":"Meuth","year":"1989","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2017.05.001_bib65","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0145-2126(89)90130-6","article-title":"The effects of thymidine on deoxyribonucleotide pool levels, cytotoxicity and mutation induction in Friend mouse erythroleukaemia cells","volume":"13","author":"Wilkinson","year":"1989","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2017.05.001_bib66","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1182\/blood-2013-12-545384","article-title":"SAMHD1: A new gene for CLL","volume":"123","author":"Rossi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.001_bib67","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1136\/annrheumdis-2013-204845","article-title":"SAMHD1 prevents autoimmunity by maintaining genome stability","volume":"74","author":"Kretschmer","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.exphem.2017.05.001_bib68","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1073\/pnas.0610585104","article-title":"Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast Saccharomyces cerevisiae","volume":"104","author":"Chabes","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2017.05.001_bib69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.virol.2016.05.002","article-title":"SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells","volume":"495","author":"Bonifati","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.exphem.2017.05.001_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1570162X14999160224094914","article-title":"The early bird catches the worm: Can evolution teach us lessons in fighting HIV?","volume":"14","author":"Schaller","year":"2016","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.exphem.2017.05.001_bib71","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrc3916","article-title":"Replication stress and cancer","volume":"15","author":"Gaillard","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2017.05.001_bib72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/15384101.2016.1261226","article-title":"Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells","volume":"16","author":"Kodigepalli","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exphem.2017.05.001_bib73","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/AAC.03903-14","article-title":"A continuous enzyme-coupled assay for triphosphohydrolase activity of HIV-1 restriction factor SAMHD1","volume":"59","author":"Arnold","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.exphem.2017.05.001_bib74","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1128\/AAC.02745-14","article-title":"SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors","volume":"58","author":"Huber","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.exphem.2017.05.001_bib75","doi-asserted-by":"crossref","first-page":"42824","DOI":"10.1038\/srep42824","article-title":"SAMHD1 enhances nucleoside-analogue efficacy against HIV-1 in myeloid cells","volume":"7","author":"Ordonez","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2017.05.001_bib76","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1016\/j.bmcl.2015.07.103","article-title":"Antiproliferative and antiplasmodial compounds from selected Streptomyces species","volume":"25","author":"Harinantenaina Rakotondraibe","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.exphem.2017.05.001_bib77","doi-asserted-by":"crossref","first-page":"e1287554","DOI":"10.1080\/23723556.2017.1287554","article-title":"SAMHD1 is a barrier to antimetabolite-based cancer therapies","volume":"4","author":"Rudd","year":"2017","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.exphem.2017.05.001_bib78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nm.4255","article-title":"SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia","volume":"23","author":"Schneider","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2017.05.001_bib79","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","article-title":"Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: A report from the Children's Oncology Group","volume":"23","author":"Berg","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.05.001_bib80","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood.V61.4.660.660","article-title":"Selective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cells","volume":"61","author":"Cohen","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.001_bib81","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1414325","article-title":"Randomized trial of TAS-102 for refractory metastatic colorectal cancer","volume":"372","author":"Mayer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2017.05.001_bib82","first-page":"638","article-title":"Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia","volume":"1","author":"Danhauser","year":"1987","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.05.001_bib83","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/JCO.1993.11.1.116","article-title":"Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy","volume":"11","author":"Gandhi","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.05.001_bib84","first-page":"897","article-title":"Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia","volume":"52","author":"Gandhi","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2017.05.001_bib85","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/0006-2952(89)90127-5","article-title":"Interaction of arabinosyl nucleotides in K562 human leukemia cells","volume":"38","author":"Gandhi","year":"1989","journal-title":"Biochem Pharmacol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17301443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17301443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T10:48:47Z","timestamp":1602067727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X17301443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":85,"alternative-id":["S0301472X17301443"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2017.05.001","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"With me or against me: Tumor suppressor and drug resistance activities of SAMHD1","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}